SCHEMBL22672663

SCHEMBL22672663

CC(C)c1cnc2c(-c3nnn[nH]3)cccc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5614238 0.74 ALDH1A1 (0.42) —
SCHEMBL22672631 0.74 PDE7A (0.33) —
SCHEMBL24174428 0.70 RAB9A (0.41) —
SCHEMBL16674962 0.70 LMNA (0.38) —
SCHEMBL22672630 0.69 PDE4A (0.32) —
SCHEMBL19919698 0.68 BTK (0.31) —
SCHEMBL2627823 0.68 TNKS2 (0.34) —
SCHEMBL17465964 0.67 TRPA1 (0.41) —
SCHEMBL9590411 0.67 NPC1 (0.35) —
SCHEMBL22672653 0.66 LRRK2 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200361920-A1 ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2020-11-19 — — US disclosed
Send feedback